CCEL

Cryo-Cell International Inc

5.35

Nov 02 • 3:21 PM ET +0.14 (2.69%)

5.27

Aftermarket • 5:00 PM ET -0.08 (-1.50%)

Healthcare Medical Care Facilities USA Nano AMEX

Peers: COO CELU NIVF BSEM MDXG IVF LGVN NTRA VCEL BRTX

| Held by: VTI VXF

Scroll to Statements

Index	-
Market Cap	43.14M
Enterprise Value	47.73M
Income	-1.95M
Sales	31.13M
Book/sh	-2.03
Cash/sh	0.52
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	May 21, 2025
Dividend Gr. 3/5Y	- -
Payout	-
Employees	76
IPO	Apr 04, 1994

P/E	-
Forward P/E	-
PEG	-
P/S	1.39
P/B	-
P/C	10.20
P/FCF	9.28
EV/EBITDA	30.99
EV/Sales	1.53
Quick Ratio	0.82
Current Ratio	0.86
Debt/Eq	-
LT Debt/Eq	-
Option/Short	No / Yes

EPS (ttm)	-0.24
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	- -
Sales past 3/5Y	1.33% 0.27%
EPS Y/Y TTM	-314.41%
Sales Y/Y TTM	-1.96%
EPS Q/Q	69.72%
Sales Q/Q	-0.02%
Earnings	Oct 09 AMC
EPS/Sales Surpr.	- -

Insider Own	47.86%
Insider Trans	0.00%
Inst Own	13.72%
Inst Trans	1.88%
ROA	-3.10%
ROE	-
ROIC	-
Gross Margin	76.17%
Oper. Margin	0.61%
Profit Margin	-6.25%
SMA20	17.32%
SMA50	23.76%
SMA200	45.05%
Trades

Shs Outstand	8.06M
Shs Float	4.20M
Short Float	0.17%
Short Ratio	0.29
Short Interest	0.01M
52W High	5.45 -1.74%
52W Low	2.72 96.69%
Volatility	7.38% 10.18%
ATR (14)	0.41
RSI (14)	66.22
Beta	0.45
Rel Volume	0.52
Avg Volume	24.23K
Volume	12,533

Perf Week	6.79%
Perf Month	34.09%
Perf Quarter	50.28%
Perf Half Y	52.42%
Perf YTD	55.53%
Perf Year	18.63%
Perf 3Y	4.70%
Perf 5Y	-51.17%
Perf 10Y	58.70%
Recom	1.00
Target Price	8.50
Prev Close	5.21
Price	5.35
Change %	2.69%

Oct-09-26 04:30PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2026 Financial Results (Business Wire)
Jul-15-26 04:30PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2026 Financial Results (Business Wire) +5.15%
May-08-26 04:00PM	Cryo-Cell Receives Acceptance of Compliance Plan From NYSE American (Business Wire)
Apr-28-26 04:00PM	Cryo-Cell International Receives FACT Re-accreditation, Setting the Longest Independently Validated Quality Track Record Among U.S. Private Cord Blood Banks (Business Wire) -14.95%
Mar-12-26 05:00PM	Cryo-Cell Receives NYSE American Continued Listing Notice (Business Wire) -6.11%
05:00PM	Loading…
Feb-27-26 05:00PM	Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2025 (Business Wire)
Aug-14-25 08:30AM	Cryo-Cell International, Inc. Provides Dividend Update (Business Wire) -9.67%
Jul-15-25 05:00PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2025 Financial Results (Business Wire)
May-08-25 05:00PM	Cord Blood Banking Leader Cryo-Cell Announces Cash Dividend (Business Wire)
Apr-16-25 11:59AM	Big banks report Q1 beats, China stops taking Boeing deliveries: Morning Buzz (TipRanks) +9.48%
Apr-15-25 08:30AM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2025 Financial Results (Business Wire)
Jan-29-25 04:15PM	Cord Blood Banking Leader Cryo-Cell Announces Regular Quarterly Cash Dividend and Pause of Strategic Initiatives (Business Wire)
Oct-30-24 08:45AM	Cord Blood Banking Leader Cryo-Cell Declares Initiation of Regular Quarterly Cash Dividend (Business Wire) +25.60%
Oct-15-24 05:20PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2024 Financial Results (Business Wire) +6.98%
Jul-15-24 04:30PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2024 Financial Results (Business Wire) -6.07%
05:00PM	Loading…
Apr-15-24 05:00PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2024 Financial Results (Business Wire) -5.37%
Mar-25-24 09:00AM	Cryo-Cell Announces Plans to Explore Strategic Alternatives and Spin-off Celle Corp. to Maximize Shareholder Value (Business Wire) +7.64%
Feb-28-24 05:00PM	Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2023 (Business Wire)
Jan-22-24 04:15PM	Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET (GlobeNewswire)
Oct-12-23 04:45PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2023 Financial Results (Business Wire)
Jul-14-23 04:15PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2023 Financial Results (Business Wire) -9.50%
Apr-21-23 04:15PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2023 Financial Results (Business Wire) +14.74%
Feb-28-23 05:15PM	Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2022 (GlobeNewswire)
Jan-24-23 11:00AM	Maxim Group LLC to Host the Healthcare IT Virtual Conference on Wednesday, January 25th at 8:15 A.M. ET (GlobeNewswire)
Oct-14-22 04:15PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2022 Financial Results (GlobeNewswire)
Aug-22-22 06:00PM	Cord Blood Banking Leader Cryo-Cell Announces Special Cash Dividend (GlobeNewswire) +15.38%
Aug-17-22 05:00PM	Cord Blood Banking Leader Cryo-Cell Announces Transfer to the NYSE American Stock Exchange (GlobeNewswire) +10.36% -7.65%
Jul-11-22 04:30PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2022 Financial Results (GlobeNewswire)
Apr-13-22 04:30PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2022 Financial Results (GlobeNewswire)
Mar-16-22 04:30PM	Cord Blood Banking Leader Cryo-Cell Announces Extravault Biorepository Service (GlobeNewswire)
04:15PM	Loading…
Mar-09-22 04:15PM	Cryo-Cell Shares Its 2021 Annual Letter to Shareholders (GlobeNewswire)
Feb-22-22 04:30PM	Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2021 (GlobeNewswire) +7.00% -10.03%
Oct-27-21 04:15PM	Cord Blood Banking Leader Cryo-Cell Announces Its Intent to Advance Clinical Trials (GlobeNewswire)
Oct-15-21 04:36PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2021 Financial Results (GlobeNewswire)
Sep-20-21 06:05PM	Cryo-Cell International Announces Changes To Its Board of Directors (GlobeNewswire) -5.45% +6.51%
Aug-30-21 09:00AM	Cryo-Cell International Announces Uplisting to The Nasdaq Capital Market (GlobeNewswire) +7.82%
Aug-20-21 09:04AM	Cryo-Cell International Completes Acquisition of Real Estate Property for Its Institute for Cellular Therapies (GlobeNewswire)
Aug-11-21 12:03PM	Cryo-Cell International to Present at the Q3 Virtual Investor Summit on August 18, 2021 (Newsfile)
09:00AM	Cryo-Cell International to Present at the Q3 Virtual Investor Summit (GlobeNewswire)
Jul-15-21 07:27PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2021 Financial Results (GlobeNewswire)
May-10-21 09:00AM	Cryo-Cell International Proudly Announces Two Ongoing COVID-19 Related Trials (GlobeNewswire)
Apr-14-21 06:14PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2021 Financial Results (GlobeNewswire)
Feb-26-21 09:30AM	Cord Blood Banking Leader Cryo-Cell International Enters Into An Exclusive License Agreement with Duke University (GlobeNewswire) +11.11%
Feb-24-21 04:30PM	Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2020 (GlobeNewswire)
Oct-15-20 04:39PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2020 Financial Results (GlobeNewswire)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
TAYMANS JILL M	VP Finance, CFO	May 28 '26	Option Exercise	3.10	7,500	23,250	52,896	May 29 04:30 PM

Cryo-Cell International, Inc. is a cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. It operates through the following segments: Umbilical Cord Blood and Cord Tissue Stem Cell Service, PrepaCyte CB, and Public Cord Blood Banking. The Umbilical Cord Blood and Cord Tissue Stem Cell Service segment refers to cellular processing and cryogenic storage of umbilical cord blood and cord tissue stem cells for family use. The PrepaCyte CB segment focuses on the manufacture of PrepaCyte CB units, the processing technology used to process umbilical cord blood stem cells. The Public Cord Blood Banking segment relates to the cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company was founded in 1989 and is headquartered in Oldsmar, FL.

Chairman & Co-CEOMr. David I. Portnoy

Co-CEO & DirectorMr. Mark L. Portnoy

CFO & VP of FinanceMs. Jill M. Taymans

Chief Information OfficerMr. Oleg Mikulinsky

Medical Director and Member of Medical & Scientific Advisory BoardDr. Joanne Kurtzberg M.D.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CCEL

Cryo-Cell International Inc

Upgrade your Finviz experience